Enveric Biosciences, Inc. · NASDAQ:ENVB
Braeden Lichti reported a 5.01% stake in Enveric Biosciences, Inc. (Schedule 13G)
Event Dec 3, 2025 · Filed Dec 5, 2025
Braeden Lichti reported a 5.01% stake in Enveric Biosciences, Inc., 29,920 shares, as a passive investor on Dec 3, 2025. Filed Dec 5, 2025 (Schedule 13G).
- Stake
- 5.01%
- Shares
- 29,920
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Braeden Lichti | 5.01% | 29,920 |
| Northstrive Fund II LP | 4.34% | 25,915 |
Source
Related
- Enveric Biosciences, Inc.
- Braeden Lichti
- Enveric Biosciences, Inc. shareholders
- Schedule 13G/A · Braeden Lichti · Dec 10, 2025
- Schedule 13G/A · Lind Global Fund III LP · Aug 14, 2026
- Schedule 13G · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Ayrton Capital LLC · Aug 13, 2026
- Form 4 · Coveney Kevin Michael · Jun 3, 2026
- Form 4 · Tucker Joseph Edward · Jun 3, 2026